The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
Open accessAbstract
SUMMARY Initiation of pancreatic ductal adenocarcinoma (PDA) is definitively linked to activating mutations in the KRAS oncogene. However, PDA mouse models show that mutant Kras expression early in development gives rise to a normal pancreas, with tumors forming only after a long latency or pancreatitis induction. Here we show that oncogenic KRAS upregulates endogenous EGFR expression and activation, the latter being dependent upon the EGFR ligand sheddase, ADAM17. Genetic ablation or pharmacological inhibition of EGFR or ADAM17 effectively eliminates KRAS-driven tumorigenesis in vivo. Without EGFR activity, active RAS levels are not sufficient to induce robust MEK/ERK activity, a requirement for epithelial transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moore, M. J., Goldstein, D., Hamm, J., Figer, A., Hecht, J. R., Gallinger, S., Au, H. J., Murawa, P., Walde, D., Wolff, R. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9525 · Cited by 3,848
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Self-citationEpidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J., Truitt, M., Gu, S., Cooc, J., Weinkle, J., Kim, G. E., Jakkula, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2344 · Cited by 1,967
Guerra, C., Schuhmacher, A. J., Cañamero, M., Grippo, P. J., Verdaguer, L., Pérez-Gallego, L., Dubus, P., Sandgren, E. P., & Barbacid, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.012 · Cited by 1,224
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors
Kawaguchi, Y., Cooper, B., Gannon, M., Ray, M., MacDonald, R. J., & Wright, C. V. E. (2002) · Nature Genetics · doi:10.1038/ng959 · Cited by 1,007 · cited 2×
“Mice KrasLSL-G12D/+, Ptf1aCre/+, Ela-Tgfa, Trp53fl/fl, Adam17DEx5/DEx5, and Egfrfl/fl strains have been described elsewhere (Hingorani et al., 2003; Kawaguchi et al., 2002; Lee and Threadgill, 2009; Marino et al., 2000; Natarajan et al., 2007; Sandgren et al., 1990; Siveke et al., 2007; Tang et…”
BackgroundDistinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
Sahin, U., Weskamp, G., Kelly, K., Zhou, H.-M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P., & Blobel, C. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200307137 · Cited by 979
Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Sandgren, E. P., Luetteke, N. C., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1990) · Cell · doi:10.1016/0092-8674(90)90075-p · Cited by 752
Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis
Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C. A., Sriuranpong, V., Iso, T., Meszoely, I. M., Wolfe, M. S., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00140-5 · Cited by 643
Self-citationBardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K.-H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 581
Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras
Gale, N. W., Kaplan, S., Lowenstein, E. J., Schlessinger, J., & Bar-Sagi, D. (1993) · Nature · doi:10.1038/363088a0 · Cited by 563
Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.011 · Cited by 516
Autocrine, paracrine and juxtacrine signaling by EGFR ligands
Singh, A. B., & Harris, R. C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.026 · Cited by 400
Morris, J. P., Cano, D. A., Sekine, S., Wang, S. C., & Hebrok, M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40045 · Cited by 366
Means, A. L., Meszoely, I. M., Suzuki, K., Miyamoto, Y., Rustgi, A. K., Coffey, R. J., Wright, C. V. E., Stoffers, D. A., & Leach, S. D. (2005) · Development · doi:10.1242/dev.01925 · Cited by 344
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Friedlander, S. Y. G., Chu, G. C., Snyder, E. L., Girnius, N., Dibelius, G., Crowley, D., Vasile, E., DePinho, R. A., & Jacks, T. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.027 · Cited by 338
Sharma, A., Zangen, D. H., Reitz, P., Taneja, M., Lissauer, M. E., Miller, C. P., Weir, G. C., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.3.507 · Cited by 331
The EGF receptor is required for efficient liver regeneration
Natarajan, A., Wagner, B., & Sibilia, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704126104 · Cited by 320
Self-citationThe EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development
Sibilia, M., Fleischmann, A., Behrens, A., Stingl, L., Carroll, J., Watt, F. M., Schlessinger, J., & Wagner, E. F. (2000) · Cell · doi:10.1016/s0092-8674(00)00026-x · Cited by 304
Self-citationStrobel, O., Dor, Y., Alsina, J., Stirman, A., Lauwers, G., Trainor, A., Castillo, C. F., Warshaw, A. L., & Thayer, S. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.009 · Cited by 266
Carrière, C., Young, A. L., Gunn, J. R., Longnecker, D. S., & Korc, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.068 · Cited by 237
Tobita, K., Kijima, H., Dowaki, S., Kashiwagi, H., Ohtani, Y., Oida, Y., Yamazaki, H., Nakamura, M., Ueyama, Y., Tanaka, M., et al. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.11.3.305 · Cited by 204
Ras Activity Levels Control the Development of Pancreatic Diseases
Ji, B., Tsou, L., Wang, H., Gaiser, S., Chang, D. Z., Daniluk, J., Bi, Y., Grote, T., Longnecker, D. S., & Logsdon, C. D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.052 · Cited by 194
Fjällskog, M.-L. H., Lejonklou, M. H., Öberg, K. E., Eriksson, B. K., & Janson, E. T. (2003) · PubMed · Cited by 189
RDEA119/BAY 869766: A Potent, Selective, Allosteric Inhibitor of MEK1/2 for the Treatment of Cancer
Iverson, C., Larson, G., Lai, C., Yeh, L.-T., Dadson, C., Weingarten, P., Appleby, T., Vo, T., Maderna, A., Vernier, J.-M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0679 · Cited by 183
Siveke, J. T., Einwächter, H., Sipos, B., Lubeseder–Martellato, C., Klöppel, G., & Schmid, R. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.002 · Cited by 157
Self-citationEarly Requirement of Rac1 in a Mouse Model of Pancreatic Cancer
Heid, I., Lubeseder–Martellato, C., Sipos, B., Mazur, P. K., Lesina, M., Schmid, R. M., & Siveke, J. T. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.043 · Cited by 141
Self-citationOncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal Cells
Lee, K. E., & Bar‐Sagi, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.020 · Cited by 138
Friess, H., Berberat, P. O., Schilling, M. K., Kunz, J., Büchler, M. W., & Korc, M. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00202070 · Cited by 137
Lüttges, J., Reinecke-Lüthge, A., Möllmann, B., Menke, M. A. O. H., Clemens, A., Klimpfinger, M., Sipos, B., & Klöppel, G. (1999) · Virchows Archiv · doi:10.1007/s004280050428 · Cited by 127
Self-citationInduction and Expression of Heparin-Binding EGF-Like Growth Factor in Human Pancreatic Cancer
Kobrin, M. S., Funatomi, H., Friess, H., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2131 · Cited by 121
Gangarosa, L. M., Sizemore, N., Graves‐Deal, R., Oldham, S., Der, C. J., & Coffey, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18926 · Cited by 118
Lisle, R. C. D., & Logsdon, C. D. (1990) · PubMed · Cited by 104
Means, A. L., Ray, K. C., Singh, A. B., Washington, M. K., Whitehead, R. H., Harris, R. C., Wright, C. V. E., Coffey, R. J., & Leach, S. D. (2003) · Gastroenterology · doi:10.1053/gast.2003.50150 · Cited by 100
Self-citationMonick, M. M., Cameron, K., Staber, J. M. R., Powers, L. S., Yarovinsky, T. O., Koland, J. G., & Hunninghake, G. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408745200 · Cited by 99
Epiregulin Is Up-Regulated in Pancreatic Cancer and Stimulates Pancreatic Cancer Cell Growth
Zhu, Z., Kleeff, J. H., Frieß, H., Wang, L., Zimmermann, A., Yarden, Y., Büchler, M. W., & Korc, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3033 · Cited by 95
Lee, T., & Threadgill, D. W. (2008) · genesis · doi:10.1002/dvg.20464 · Cited by 95
Self-citationJimeno, A., Tan, A. C., Coffa, J., Rajeshkumar, N. V., Kulesza, P., Rubio‐Viqueira, B., Wheelhouse, J., Diosdado, B., Messersmith, W. A., Iacobuzio–Donahue, C. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5200 · Cited by 93
Korc, M., Frieß, H., Yamanaka, Y., Kobrin, M. S., Büchler, M. W., & Beger, H. G. (1994) · Gut · doi:10.1136/gut.35.10.1468 · Cited by 91
Larbouret, C., Robert, B., Navarro‐Teulon, I., Thézenas, S., Ladjemi, M. Z., Morisseau, S., Campigna, E., Bibeau, F., Mach, J., Pèlegrin, A., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2302 · Cited by 90
Mascia, F., Cataisson, C., Lee, T.-C., Threadgill, D. W., Mariani, V., Amerio, P., Chandrasekhara, C., Adeva, G. S., Girolomoni, G., Yuspa, S. H., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.336 · Cited by 83
Self-citationDlugosz, A. A., Hansen, L. A., Cheng, C., Alexander, N., Denning, M. F., Threadgill, D. W., Magnuson, T., Coffey, R. J., & Yuspa, S. H. (1997) · PubMed · Cited by 80
Self-citationRole of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor.
Basu, T., Ph, W., & Downward, J. (1994) · PubMed · Cited by 80
Ringel, J., Jesnowski, R., Moniaux, N., Lüttges, J., Ringel, J., Choudhury, A., Batra, S. K., Klöppel, G., & Löhr, M. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3287 · Cited by 75
Hansen, L. A., Woodson, R. L., Holbus, S., Strain, K., Lo, Y. C., & Yuspa, S. H. (2000) · PubMed · Cited by 72
Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma
Bardeesy, N. M., Kim, M., Xu, J., Kim, R.-S., Shen, Q. “., Bosenberg, M., Wong, W. H., & Chin, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4176-4188.2005 · Cited by 70
Pino, M. S., Shrader, M., Baker, C. H., Cognetti, F., Xiong, H. Q., Abbruzzese, J. L., & McConkey, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3753 · Cited by 60
Tang, J., Zarbock, A., Gomez, I. G., Wilson, C. L., Lefort, C. T., Stadtmann, A., Bell, B., Huang, L.-C., Ley, K. F., & Raines, E. W. (2011) · Blood · doi:10.1182/blood-2010-11-321406 · Cited by 55
Self-citationZhao, S., Wang, Y., Cao, L., Ouellette, M. M., & Freeman, J. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25412 · Cited by 49
Jaganathan, S., Yue, P., & Turkson, J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162669 · Cited by 38
Measuring Ras-family GTP levels in vivo—running hot and cold
Castro, A. F., Rebhun, J. F., & Quilliam, L. A. (2005) · Methods · doi:10.1016/j.ymeth.2005.05.015 · Cited by 36
Cited by
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
RAS-targeted therapies: is the undruggable drugged?
Moore, A. R., Rosenberg, S. C., McCormick, F., & Malek, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0068-6 · Cited by 1,103
Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Buscail, L., Bournet, B., & Cordelier, P. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0245-4 · Cited by 721
Kopp, J. L., von Figura, G., Mayes, E., Liu, F.-F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V. E., Jensen, K., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.025 · Cited by 697
Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design
Ostrem, J. M. L., & Shokat, K. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.139 · Cited by 641
Metadata
- Authors
- Ardito, C. M., Grüner, B. M., Takeuchi, K. K., Lubeseder-Martellato, C., Teichmann, N., Mazur, P. K., DelGiorno, K. E., Carpenter, E. S., Halbrook, C. J., Hall, J. C., Pal, D., Briel, T., Herner, A., Trajkovic-Arsic, M., Sipos, B., Liou, G.-Y., Storz, P., Murray, N. R., Threadgill, D. W., Sibilia, M., Washington, M. K., Wilson, C. L., Schmid, R. M., Raines, E. W., Crawford, H. C., & Siveke, J. T.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 22
- Issue
- 3
- Pages
- 304-317
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1969201526
- Cited by
- 517
- References
- 52
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.